Quadrivalent Human Papillomavirus Vaccine Clears Recalcitrant Warts in Idiopathic Immune Deficiency Case
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clearance of Recalcitrant Warts in a Patient With Idiopathic Immune Deficiency Following Administration of the Quadrivalent Human Papillomavirus Vaccine
Clin Exp Dermatol 2017 Jan 10;[EPub Ahead of Print], SP Smith, HE Baxendale, JC SterlingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.